Clinical Trial Update: Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections [Phase 1]

View source ↗

Summary

Phase 1 dose-finding, pharmacokinetics, and safety study of Vabomere (meropenem-vaborbactam) in pediatric patients with bacterial infections; the trial is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections

Drugs mentioned

• VABOMERE (MEROPENEM-VABORBACTAM)

Snippet

Sponsor: Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC) | Conditions: Bacterial Infections | Phase 1 | Status: ACTIVE_NOT_RECRUITING